Jessica Maples-Keller
Associate Professor in the Emory School of Medicine, Department of Psychiatry and Behavioral Sciences; Associate Director of the Emory Healthcare Veterans Program
Data updated
Research Footprint
Jessica Maples-Keller appears in 5 tracked papers (2022–2024), most studied alongside MDMA and Psilocybin, across PTSD, Depressive Disorders and Anxiety Disorders.
Most-cited paper: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (1057 citations).
Frequent co-authors: Katharine Dunlop, Boadie Dunlop and Matthew Johnson.
Background & Research
Jessica Maples-Keller, PhD, is an Associate Professor in the Emory School of Medicine’s Department of Psychiatry and Behavioral Sciences. Her research focuses on translational models to improve exposure-based treatment for PTSD and on behavioral and pharmacological augmentation of psychotherapy, including MDMA and psilocybin. She is also interested in equity, access, personality, and psychopathology, and she practices clinically in exposure-based interventions for PTSD.
Key Impact
She is a prominent translational PTSD and psychedelic-therapy researcher contributing to MDMA and psilocybin studies, including work on fear extinction, treatment barriers, and culturally informed psychedelic-assisted therapy.
Collaboration Network
28 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Jessica Maples-Keller is associated with.